The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups

作者: J Cabezas-Cerrato , Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS) , None

DOI: 10.1007/S001250051063

关键词: SurgeryEpidemiologyOutpatient clinicDiabetes mellitusCross-sectional studyDiabetic footInternal medicineConfidence intervalAmputationPolyneuropathyMedicine

摘要: A multiregional cross-sectional study of clinical diabetic polyneuropathy (DPN) was carried out among Spanish diabetes patients using a standard system for scoring symptoms and signs polyneuropathy. The main patient sample comprised 2 644 (54.7 % women) aged 15–74 years (mean 57.2 ± 0.3 years), 86.9 whom had Type II (non-insulin-dependent) mellitus 29.4 were attending hospital clinics. Mean duration since diagnosis 10.2 0.2 years. prevalence DPN 22.7 (95 confidence interval 21.2–24.3 %) in the whole sample, 12.9 (9.4–16.5 with I (insulin-dependent) 24.1 (22.4–25.9 diabetes; there no significant difference between men women. Prevalence increased age (from 30 years). In supplementary 161 75 to 79 (excluded from prevent confusion diabetes-induced ageing-induced neuropathies), 37.8 %. Ninety-three (3.3 or foot ulcers 21 these 93 (0.7 undergone amputation; 90.8 ulcerated diabetes, 54 (in most cases loss perception vibration), as against 19.9 without ulcers. We conclude that nearly quarter have DPN; over 90 increases disease, risk is about three times DPN. accordingly emphasize responsibility primary care physicians try lesions by early [Diabetologia (1998) 41: 1263–1269]

参考文章(34)
Keen H, The Diabetes Control and Complications Trial (DCCT). Health trends. ,vol. 26, pp. 41- 43 ,(1994)
J P Whisnant, P J Palumbo, L R Elveback, Neurologic complications of diabetes mellitus: transient ischemic attack, stroke, and peripheral neuropathy. Advances in Neurology. ,vol. 19, pp. 593- 601 ,(1978)
Peter James Dyck, Caterina Giannini, Pathologic alterations in the diabetic neuropathies of humans: a review. Journal of Neuropathology and Experimental Neurology. ,vol. 55, pp. 1181- 1193 ,(1996) , 10.1097/00005072-199612000-00001
M. I. Harris, R. Klein, T. A. Welborn, M. W. Knuiman, Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis Diabetes Care. ,vol. 15, pp. 815- 819 ,(1992) , 10.2337/DIACARE.15.7.815
A. J. M. Boulton, G. Knight, J. Drury, J. D. Ward, The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population. Diabetes Care. ,vol. 8, pp. 125- 128 ,(1985) , 10.2337/DIACARE.8.2.125
M. L. Sands, S. M. Shetterly, G. M. Franklin, R. F. Hamman, Incidence of Distal Symmetric (Sensory) Neuropathy in NIDDM: The San Luis Valley Diabetes Study Diabetes Care. ,vol. 20, pp. 322- 329 ,(1997) , 10.2337/DIACARE.20.3.322
M. J. Young, A. J. M. Boulton, A. F. Macleod, D. R. R. Williams, P. H. Sonksen, A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population Diabetologia. ,vol. 36, pp. 150- 154 ,(1993) , 10.1007/BF00400697
P. J. Dyck, K. M. Kratz, K. A. Lehman, J. L. Karnes, L. J. Melton, P. C. O'Brien, W. J. Litchy, A. J. Windebank, B. E. Smith, P. A. Low, F. J. Service, R. A. Rizza, B. R. Zimmerman, The Rochester Diabetic Neuropathy Study Design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests Neurology. ,vol. 41, pp. 799- 799 ,(1991) , 10.1212/WNL.41.6.799